Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy
NCT00005955Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in Malignant Central Nervous System Tumor, sponsored by Duke University. Started Aug 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
Malignant Central Nervous System Tumor
Beyond the preview
Go deeper on NCT00005955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005955.